The effectiveness of varicella vaccination in children in Germany: A case-control study

Pediatric Infectious Disease Journal

Volumn 32, Issue 9, 2013, Pages 998-1004

  Liese, Johannes G ^a,b   Cohen, Carine ^c   Rack, Anita ^b   Pirzer, Kerstin ^b   Eber, Stefan ^d   Blum, Maxim ^c   Greenberg, Michael ^c,e   Streng, Andrea ^a,b  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c GSK   (Belgium)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e SANOFI PASTEUR   (France)

Author keywords

Children; Germany; Vaccination; Varicella

Indexed keywords

CHICKENPOX VACCINE; MEASLES MUMPS RUBELLA VACCINE;

ARTICLE; CASE CONTROL STUDY; CHICKENPOX; CHILD; CLINICAL EFFECTIVENESS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; FOLLOW UP; GERMANY; HUMAN; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINGLE DRUG DOSE; VACCINATION;

CASE-CONTROL STUDIES; CHICKENPOX; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; FEMALE; GERMANY; HUMANS; INFANT; MALE; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; VACCINATION;

EID: 84891626348     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31829ae263     Document Type: Article

References (48)

1. Heininger U, Seward JF. Varicella. Lancet. 2006;368:1365-1376.
2. Wharton M. The epidemiology of varicella-zoster virus infections. Infect Dis Clin North Am. 1996;10:571-581.
3. Weinberg JM. Herpes zoster: epidemiology, natural history, and common complications. J Am Acad Dermatol. 2007;57(suppl 6):S130-S135.
4. Wutzler P, Färber I, Wagenpfeil S, et al. Seroprevalence of varicella-zoster virus in the German population. Vaccine. 2001;20:121-124.
5. Liese JG, Grote V, Rosenfeld E, et al.; ESPED Varicella Study Group. The burden of varicella complications before the introduction of routine varicella vaccination in Germany. Pediatr Infect Dis J. 2008;27:119-124.
6. Rack AL, Grote V, Streng A, et al. Neurologic varicella complications before routine immunization in Germany. Pediatr Neurol. 2010;42:40-48.
7. Grote V, Von Kries R, Springer W, et al. Varicella-related deaths in children and adolescents-Germany 2003-2004. Acta Paediatr. 2008;97:187-192.
8. Marin M, Zhang JX, Seward JF. Near elimination of varicella deaths in the US after implementation of the vaccination program. Pediatrics. 2011;128:214-220.
9. Calendrier Vaccinal Recommandé au Luxembourg. Available at: http://www.sante.public.lu/fr/rester-bonne-sante/120-vaccinations/ calendrier-vaccinal/index.html. Accessed March 6, 2012.
10. Boletin Epidemiológico de la Comunidad de Madrid. Varicela en la Comunidad de Madrid, Años 2001 a 2009. 2010;16:3-22.
11. Alfonsi V, D'Ancona F, Giambi C, et al.; Regional Coordinators for Infectious Diseases and Vaccinations. Current immunization policies for pneumococcal, meningococcal C, varicella and rotavirus vaccinations in Italy. Health Policy. 2011;103:176-183.
12. Bonanni P, Breuer J, Gershon A, et al. Varicella vaccination in Europe - taking the practical approach. BMC Med. 2009;7:26.
13. Quian J, Rüttimann R, Romero C, et al. Impact of universal varicella vaccination on 1-year-olds in Uruguay: 1997-2005. Arch Dis Child. 2008;93:845-850.
14. Reuss AM, Feig M, Kappelmayer L, et al. Varicella vaccination coverage of children under two years of age in Germany. BMC Public Health. 2010;10:502.
15. Gavrielov-Yusim N, Battat E, Neumann L, et al. Birth order and private voluntary immunization-a study of 110, 902 children. Vaccine. 2012;30:442-447.
16. Robert Koch Institut. Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch Institut/Stand: Juli 2004. Epidemiol Bull. 2004;30:235-250.
17. Streng A, Seeger K, Grote V, et al. Varicella vaccination coverage in Bavaria (Germany) after general vaccine recommendation in 2004. Vaccine. 2010;28:5738-5745.
18. Hohle M, Siedler A, Bader HM, et al. Assessment of varicella vaccine effectiveness in Germany: a time-series approach. Epidemiol Infect. 2011;139:1710-1719.
19. Robert Koch Institut. Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch Institut/Stand: Juli 2009. Epidemiol Bull. 2009;30:279-298.
20. Chaves SS, Zhang J, Civen R, et al. Varicella disease among vaccinated persons: clinical and epidemiological characteristics, 1997-2005. J Infect Dis. 2008;197(suppl 2):S127-S131.
21. Guris D, Jumaan AO, Mascola L, et al. Changing varicella epidemiology in active surveillance sites-United States, 1995-2005. J Infect Dis. 2008;197(suppl 2):S71-S75.
22. Shah SS, Wood SM, Luan X, et al. Decline in varicella-related ambulatory visits and hospitalizations in the United States since routine immunization against varicella. Pediatr Infect Dis J. 2010;29:199-204.
23. Vázquez M, La Russa PS, Gershon AA, et al. The effectiveness of the varicella vaccine in clinical practice. N Engl J Med. 2001;344:955-960.
24. Vázquez M, La Russa PS, Gershon AA, et al. Effectiveness over time of varicella vaccine. JAMA. 2004;291:851-855.
25. Shapiro ED, Vazquez M, Esposito D, et al. Effectiveness of 2 doses of varicella vaccine in children. J Infect Dis. 2011;203:312-315.
26. Seward JF, Marin M, Vázquez M. Varicella vaccine effectiveness in the US vaccination program: a review. J Infect Dis. 2008;197(suppl 2):S82-S89.
27. Bayer O, Heininger U, Heiligensetzer C, et al. Metaanalysis of vaccine effectiveness in varicella outbreaks. Vaccine. 2007;25:6655-6660.
28. Sheffer R, Segal D, Rahamani S, et al. Effectiveness of the Oka/GSK attenuated varicella vaccine for the prevention of chickenpox in clinical practice in Israel. Pediatr Infect Dis J. 2005;24:434-437.
29. Fu C, Wang M, Liang J, et al. The effectiveness of varicella vaccine in China. Pediatr Infect Dis J. 2010;29:690-693.
30. Bavarian Statistical Office. Available at: https://www.statistik.bayem. de. Accessed March 6, 2012.
31. Mols JF, Ledent E, Heineman TC. Sampling of herpes zoster skin lesion types and the impact on viral DNA detection. J Virol Methods. 2013;188:145-147.
32. Chaves SS, Gargiullo P, Zhang JX, et al. Loss of vaccine-induced immunity to varicella over time. N Engl J Med. 2007;356:1121-1129.
33. Niccolai LM, Ogden LG, Muehlenbein CE, et al. Methodological issues in design and analysis of a matched case-control study of a vaccine's effectiveness. J Clin Epidemiol. 2007;60:1127-1131.
34. Michalik DE, Steinberg SP, La Russa PS, et al. Primary vaccine failure after 1 dose of varicella vaccine in healthy children. J Infect Dis. 2008;197:944-949.
35. Marin M, Güris D, Chaves SS, et al.; Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC). Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56(RR-4):1-40.
36. Marin M, Meissner HC, Seward JF. Varicella prevention in the United States: a review of successes and challenges. Pediatrics. 2008;122:e744-e751.
37. Shapiro ED. Case-control studies of the effectiveness of vaccines: validity and assessment of potential bias. Pediatr Infect Dis J. 2004;23:127-131.
38. Chaves SS, Lopez AS, Watson TL, et al. Varicella in infants after implementation of the US varicella vaccination program. Pediatrics. 2011;128:1071-1077.
39. Skull SA, Wang EE. Varicella vaccination-a critical review of the evidence. Arch Dis Child. 2001;85:83-90.
40. Passwell JH, Hemo B, Levi Y, et al. Use of a computerized database to study the effectiveness of an attenuated varicella vaccine. Pediatr Infect Dis J. 2004;23:221-226.
41. Arnedo-Pena A, Puig-Barberà J, Aznar-Orenga MA, et al. Varicella vaccine effectiveness during an outbreak in a partially vaccinated population in Spain. Pediatr Infect Dis J. 2006;25:774-778.
42. Miron D, Lavi I, Kitov R, et al. Vaccine effectiveness and severity of varicella among previously vaccinated children during outbreaks in day-care centers with low vaccination coverage. Pediatr Infect Dis J. 2005;24:233-236.
43. Quian RJ, Protasio PA, Dall'orso VP, et al. Varicella outbreak in a village in Uruguay. Rev Chilena Infectol. 2010;27:47-51.
44. Siedler A, Arndt U. Impact of the routine varicella vaccination programme on varicella epidemiology in Germany. Euro Surveill. 2010;15:19530.
45. Spackova M, Wiese-Posselt M, Dehnert M, et al. Comparative varicella vaccine effectiveness during outbreaks in day-care centres. Vaccine. 2010;28:686-691.
46. Marchetti F, Cuccia M. The effectiveness of Varivax and Varilrix vaccines. Vaccine. 2010;28:4859-4860.
47. Verstraeten T, Jumaan AO, Mullooly JP, et al.; Vaccine Safety Datalink Research Group. A retrospective cohort study of the association of varicella vaccine failure with asthma, steroid use, age at vaccination, and measlesmumpsrubella vaccination. Pediatrics. 2003;112:e98-103.
48. Outbreak of varicella among vaccinated children-Michigan, 2003. MMWR Morb Mortal Wkly Rep. 2004;53:389-392.